OncoNano Medicine
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $49M
Investors
- 2
About OncoNano Medicine
OncoNano Medicine, Inc.Founded in 2014, OncoNano Medicine, Inc. operates from its headquarters in Southlake, US, and specializes in developing treatments for cancer.OncoNano Medicine, Inc. focuses on developing cutting-edge therapeutic solutions that enhance drug delivery for cancer treatment. Their primary product offerings are centered around innovative technologies that improve the effectiveness of cancer medications, particularly in targeting and treating tumors.The company's revenue is generated through various channels associated with its therapeutic development programs and partnerships in the biopharmaceutical industry. Clients typically engage in long-term agreements that ensure ongoing collaboration in drug development and testing.S. and Europe. Additionally, the company aims to accelerate the advancement of its first therapeutic development program. The strategic focus includes potential expansion into new geographic markets, particularly within Europe, by 2023, enhancing their global reach in cancer treatment solutions.
Who invested in OncoNano Medicine
2 investors across 1 round
See all investors in OncoNano Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 15, 2021
Amount
$49M
Investors
Questions about OncoNano Medicine
Who invested in OncoNano Medicine?
OncoNano Medicine has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoNano Medicine raised?
OncoNano Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did OncoNano Medicine last raise money?
OncoNano Medicine's most recent round on record is a Series B, in Jun 2021.
What does OncoNano Medicine do?
OncoNano Medicine is a biotechnology company.
Where is OncoNano Medicine headquartered?
OncoNano Medicine is headquartered in Southlake, US.
Which VCs invest in companies like OncoNano Medicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OncoNano Medicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like OncoNano Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.